These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9093040)

  • 21. Transseptal defibrillation is superior for transvenous defibrillation.
    Singer I; Goldsmith J; Maldonado C
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):229-32. PubMed ID: 7724405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of biphasic shock duration on defibrillation threshold with different electrode configurations and phase 2 capacitances: prediction by upper-limit-of-vulnerability determination.
    Schauerte PN; Ziegert K; Waldmann M; Schöndube FA; Birkenhauer F; Mischke K; Grossmann M; Hanrath P; Stellbrink C
    Circulation; 1999 Mar; 99(11):1516-22. PubMed ID: 10086978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of implantable cardioverter/defibrillator lead placement in the right ventricle on defibrillation energy requirements. A combined experimental and clinical study.
    Winter J; Heil JE; Schumann C; Lin Y; Schannwell CM; Michel U; Schipke JD; Schulte HD; Gams E
    Eur J Cardiothorac Surg; 1998 Oct; 14(4):419-25. PubMed ID: 9845149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fully discharging phases. A new approach to biphasic waveforms for external defibrillation.
    Yamanouchi Y; Brewer JE; Olson KF; Mowrey KA; Mazgalev TN; Wilkoff BL; Tchou PJ
    Circulation; 1999 Aug; 100(8):826-31. PubMed ID: 10458718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of shock waveform configuration on the defibrillation capacity of implantable cardioverter defibrillators in dogs.
    Pariaut R; Saelinger C; Vila J; Deforge W; Queiroz-Williams P; Beaufrère H; Zimmerman M; Saile K; Reynolds CA
    J Vet Cardiol; 2012 Sep; 14(3):389-98. PubMed ID: 22819488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans.
    Cooper RA; Plumb VJ; Epstein AE; Kay GN; Ideker RE
    Circulation; 1998 Jun; 97(25):2527-35. PubMed ID: 9657473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large change in voltage at phase reversal improves biphasic defibrillation thresholds. Parallel-series mode switching.
    Yamanouchi Y; Mowrey KA; Nadzam GR; Hills DG; Kroll MW; Brewer JE; Donohoo AM; Wilkoff BL; Tchou PJ
    Circulation; 1996 Oct; 94(7):1768-73. PubMed ID: 8840873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracardiac atrial defibrillation.
    Dosdall DJ; Ideker RE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S51-6. PubMed ID: 17336885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward Miniaturization of Defibrillators: Design of a Defibrillation Charge/Discharge Circuit.
    Huang Y; Wen X; Wang J; Jin L; Qian L; Wu X
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():6155-6158. PubMed ID: 31947248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leakage of energy to the body surface during defibrillation shock by an implantable cardioverter-defibrillator (ICD) system--experimental evaluation during defibrillation shocks through the right ventricular lead and the subcutaneous active-can in canines.
    Niwano S; Kitano Y; Moriguchi M; Yoshizawa N; Kashiwa T; Suyama M; Toyoshima T; Izumi T
    Jpn Circ J; 2001 Mar; 65(3):219-25. PubMed ID: 11266198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vector magnitude using orthogonal ECG leads during ventricular fibrillation is associated with defibrillation outcome.
    Gurunathan S; Hsia PW; Lawton J; Hua DP
    Biomed Instrum Technol; 1998; 32(1):48-61. PubMed ID: 9475962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Woven wire patches are superior to solid disks for subcutaneous electrodes: implications for active can defibrillation.
    Leonelli FM; Wright H; Brewer JE; Adams TP; Kroll MW
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):225-8. PubMed ID: 7724404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of the impulse form of the defibrillation shock on its effectiveness and device technology of the implantable cardiac defibrillator].
    Jung W; Manz M; Lüderitz B
    Herz; 1994 Oct; 19(5):251-8. PubMed ID: 8001898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrode surface area is an important variable for defibrillation.
    Singer I; Goldsmith J; Maldonado C
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):233-6. PubMed ID: 7724406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of electrode size on transvenous defibrillation energy requirements: a prospective evaluation.
    Halperin BD; Reynolds B; Fain ES; Ligon DA; Silka MJ
    Pacing Clin Electrophysiol; 1997 Apr; 20(4 Pt 1):893-8. PubMed ID: 9127393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized first phase tilt in "parallel-series" biphasic waveform.
    Yamanouchi Y; Mowrey KA; Kroll MW; Brewer JE; Donohoo AM; Wilkoff BL; Tchou PJ
    J Cardiovasc Electrophysiol; 1997 Jun; 8(6):649-57. PubMed ID: 9209966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a Unique Defibrillation Unit with Dual-Vector Biphasic Waveform Capabilities: Towards a Miniaturized Defibrillator.
    Okamura H; Desimone CV; Killu AM; Gilles EJ; Tri J; Asirvatham R; Ladewig DJ; Suddendorf SH; Powers JM; Wood-Wentz CM; Gray PD; Raymond DM; Savage SJ; Savage WT; Bruce CJ; Asirvatham SJ; Friedman PA
    Pacing Clin Electrophysiol; 2017 Feb; 40(2):108-114. PubMed ID: 27990645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic evaluation of the determinants of defibrillation efficacy.
    Nanthakumar K; Newman D; Paquette M; Dorian P
    Heart Rhythm; 2005 Jan; 2(1):36-41. PubMed ID: 15851263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.